• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Study Finds Diabetes a Risk Factor for Excess Antibiotic Use


A large Danish study compared community antibiotic use and hospital-treated infections between people with and without type 2 diabetes.

How do community-dispensed antibiotics and hospital-treated infections differ between people with type 2 diabetes (T2D) and the general population? In this Medical News Minute, developed exclusively for Consultantlive.com, Dr. Bobby Lazzara reviews a Danish study that tracked community- and hospital-treated infections in approximately 774,017 controls; of these, 155,158 had T2D. The observational study ran from 2004 to 2012.

Results, perhaps as expected: People with T2D were up to 55% more likely to experience hospital-treated infections and up to 30% more likely to receive an antibiotic prescription in the community setting vs the general population. What might not have been expected, however, was an observed change in the annual risk of both variables, which Dr Lazzara explains in this brief video.

The study abstract is available here: Mor A, Berencsi K, Nielsen JS, et al. Rates of community-based antibiotic prescriptions and hospital-treated infections in individuals with and without type 2 diabetes: a Danish nationwide cohort study, 2004–2012. Clin Infect Dis. (2016)  doi: 10.1093/cid/ciw345 First published online: June 26, 2016.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.